Clinical Trials
3 trialsNCT02723864 2022-02-08
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00678132 2018-07-05
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00022178 2013-09-20
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
National Cancer Institute (NCI)
Phase 3 Unknown